Shares of MBX Biosciences, Inc. (MBX) have gained 44% over the past four weeks to close the last trading session at $20, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$37.71 indicates a potential upside of 88.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $4.23. While the lowest estimate of$30.00 indicates a 50% increase from the cu ...